Capital Management Associates (New York)’s Eli Lilly LLY Stock Holding History

Capital Management Associates (New York)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.39M	Hold	2,600	–	–	3.97%	7
2025 Q4	$2.79M	Hold	2,600	–	–	4.1%	3
2025 Q3	$1.98M	Buy	2,600 +1,000	+63%	+$744K	2.96%	14
2025 Q2	$1.25M	Hold	1,600	–	–	2.04%	24
2025 Q1	$1.32M	Hold	1,600	–	–	2.58%	19
2024 Q4	$1.24M	Hold	1,600	–	–	1.45%	26
2024 Q3	$1.42M	Hold	1,600	–	–	1.58%	20
2024 Q2	$1.45M	Hold	1,600	–	–	1.72%	20
2024 Q1	$1.24M	Buy	+1,600	New	+$1.14M	1.48%	27
2023 Q1	–	Sell	-3,750	Closed	-$1.37M	–	96
2022 Q4	$1.37M	Buy	3,750 +1,250	+50%	+$443K	2.04%	18
2022 Q3	$808K	Hold	2,500	–	–	1.18%	37
2022 Q2	$810K	Buy	2,500 +2,250	+900%	+$675K	1.19%	39
2022 Q1	$72K	Buy	+250	New	+$64.3K	0.08%	64
2019 Q2	–	Sell	-6,600	Closed	-$856K	–	108
2019 Q1	$856K	Hold	6,600	–	–	1.33%	19
2018 Q4	$764K	Buy	+6,600	New	+$737K	1.45%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Management Associates (New York)'s LLY Position: Q1 2026 in Review

Capital Management Associates (New York) held its Eli Lilly (LLY) position steady in Q1 2026 at 2,600 shares worth $2.39M. The position accounts for 3.97% of the portfolio, ranked #7.

Capital Management Associates (New York) first reported a position in LLY in Q4 2018 and has held it in 15 quarters since. The position peaked at $2.79M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Capital Management Associates (New York) held 2,600 shares of Eli Lilly worth $2.39M as of Q1 2026.
Capital Management Associates (New York) left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 3.97% of Capital Management Associates (New York)'s portfolio in Q1 2026, its #7 holding.
Capital Management Associates (New York) first reported a position in Eli Lilly in Q4 2018 and has held it in 15 quarters since.
Capital Management Associates (New York)'s Eli Lilly position peaked at $2.79M in Q4 2025.
4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2026, filed 4 May 2026.